BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21414306)

  • 1. Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats.
    Restrepo B; García M; Rodríguez-Barbero A; Román LS; Martin ML; Morán A
    Eur J Pharmacol; 2011 May; 659(1):37-44. PubMed ID: 21414306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.
    Morán A; Ortiz de Urbina AV; Martín ML; García M; Rodriguez-Barbero A; Dorado F; San Román L
    Eur J Pharmacol; 2008 Sep; 592(1-3):133-7. PubMed ID: 18644367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats.
    Morán A; de Urbina AV; Martín ML; Rodríguez-Barbero A; Román LS
    Eur J Pharmacol; 2009 Oct; 620(1-3):90-6. PubMed ID: 19699736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation.
    Fernández MM; Morán A; Martín ML; San Román L
    Eur J Pharmacol; 2000 Aug; 401(2):221-7. PubMed ID: 10924930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal vasoconstrictor response to 5-hydroxytryptamine in the in situ autoperfused rat kidney: involvement of angiotensin II and the 5-HT2 receptor activation.
    Morán A; Velasco C; Martín ML; San Román L
    Eur J Pharmacol; 1997 Jul; 330(2-3):205-11. PubMed ID: 9253955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats.
    Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L
    Pharmacology; 2004 Jun; 71(2):66-72. PubMed ID: 15118345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
    Calama E; Fernández MM; Morán A; Martín ML; San Román L
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
    Calama E; Ortíz de Urbina AV; Morán A; Martín ML; San Román L
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
    García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature.
    García-Pedraza JA; García M; Martín ML; Rodríguez-Barbero A; Morán A
    Vascul Pharmacol; 2016 Apr; 79():51-59. PubMed ID: 26586311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclooxygenase and nitric oxide synthesis/pathways mediate the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats.
    Restrepo B; García M; López C; Martín ML; San Román L; Morán A
    Pharmacology; 2012; 90(3-4):169-76. PubMed ID: 22948792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evidence that 5-HT1D activation induces renal vasodilation by NO pathway in rats.
    García-Pedraza JÁ; García M; Martín ML; Morán A
    Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):640-7. PubMed ID: 25854421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats.
    García-Pedraza JÁ; García M; Martín ML; San Román L; Morán A
    Eur J Pharmacol; 2014 May; 731():80-7. PubMed ID: 24675150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat.
    García M; Morán A; Calama E; Martín ML; Barthelmebs M; Román LS
    Br J Pharmacol; 2005 Jul; 145(5):593-601. PubMed ID: 15852039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated 5-hydroxytryptamine receptor-mediated responses in aortae from streptozotocin-induced diabetic rats.
    James GM; Hodgson WC; Davis EA; Haynes JM
    Br J Pharmacol; 1994 Jan; 111(1):370-6. PubMed ID: 8012721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.
    García-Pedraza JÁ; García M; Martín ML; Morán A
    Vascul Pharmacol; 2015 Sep; 72():172-80. PubMed ID: 26003124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of 5-hydroxytryptamine-induced inhibition on the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats.
    Morán A; Restrepo B; de Urbina AV; García M; Martín ML; Román LS
    Eur J Pharmacol; 2010 Sep; 643(1):70-7. PubMed ID: 20547148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs.
    Villalón CM; Ramírez-San Juan E; Castillo C; Castillo E; López-Muñoz FJ; Terrón JA
    Br J Pharmacol; 1995 Nov; 116(6):2778-84. PubMed ID: 8591004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
    Watts SW; Thompson JM
    J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
    Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
    Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.